Contents, Vol. 94, 1995
Y.C. Linn, Uğur Yılmaz, Patrick Tan(SingHealth), Purvish M. Parikh(Tata Memorial Hospital), A. S. Raste, Kendo Kiyosawa, Satoko Gaun, I.A. Park, P.S.R.K. Sastry, Sylvie Caulet-Maugendre, Hiroaki Naoe, Yeow Tee Goh(Singapore General Hospital), R.M. Hedge, Beate Schmitz(Biofrontera (Germany)), Laurence Amiot, Shigenori Higuchi, Robin Gopal, V.C. Karkhanis, Hiroyuki Nunoi(Unknown), Nitin Inamdar(Tata Memorial Hospital), Cavit Çehrelı, Bülent Ündar, Kaoru Uchimaru(University of Tokyo Hospital), Bernard Drénou(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), L Lee, J Goasguen, J. Thiele, Bahriye Payzın, Patrick Tas(Inserm), Atsuko Narita, Hikaru Kobayashi, Hiroshi Saito(Nihon Pharmaceutical University), Paul A. Sanders, S.L. Tien, G. Teoh, Mitsuomi Hirashima, R. Fischer(Unknown), Kazuo Aoki(National Cheng Kung University), Ichiro Matsuda, P. Y. Le Prise, S H Advani, Kiyoshi Kitano, Masahide Watanabe, Toru Motokura, R Fauchet, Akimasa Higashi, R. Kaufmann, L.C. Lim, I.E. Burton
Cited by 0
Related Papers
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2006|705
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483
Genomic basis for RNA alterations in cancer
|Nature|2020|426